Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
Ranibizumab and bevacizumab are both monoclonal antibody fragments (Fab) derived from the same parent mouse antibody.